In vivo, ex vivo and in vitro dasatinib activity in chronic lymphocytic leukemia

Dasatinib inhibits the breakpoint cluster region-Abelson murine leukemia 1 (BCR-ABL1) gene along with other kinases known to be overexpressed and abnormally active in patients with chronic lymphocytic leukemia (CLL). The current study used primary leukemic cells obtained from 53 patients with CLL th...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncol Lett
Main Authors: Giannopoulos, Krzysztof, Karczmarczyk, Agnieszka, Karp, Marta, Bojarska-Junak, Agnieszka, Kosior, Kamila, Kowal, Małgorzata, Tomczak, Waldemar, Hus, Marek, Machnicki, Marcin, Stokłosa, Tomasz
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2021
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7905539/
https://ncbi.nlm.nih.gov/pubmed/33732361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2021.12546
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki